(Q44144955)

30 November 2017

Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate (English)

1 reference

30 November 2017

Matthew J Baker

1

1 reference

30 November 2017

Steven Brem

2

1 reference

30 November 2017

Stephanie Daniels

3

1 reference

30 November 2017

Beverly Sherman

4

1 reference

30 November 2017

Surasak Phuphanich

5

1 reference

30 November 2017

1 September 2002

1 reference

Journal of Neuro-Oncology

30 November 2017

1 reference

30 November 2017

59

1 reference

30 November 2017

3

1 reference

30 November 2017

239-242

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1019905127442

30 November 2017

0 references

cites work

Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.

1 reference

12 December 2020

Phenylacetate and phenylbutyrate as novel, nontoxic differentiation inducers

1 reference

12 December 2020

The New Approaches to Brain Tumor Therapy (NABTT) CNS Consortium: Organization, Objectives, and Activities

1 reference

12 December 2020

Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents

1 reference

12 December 2020

Perspectives in the treatment of malignant gliomas in adults.

1 reference

12 December 2020

Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma

1 reference

12 December 2020

Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

1 reference

12 December 2020

Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells

1 reference

12 December 2020

Inhibitory effects of phenylbutyrate on the proliferation, morphology, migration and invasiveness of malignant glioma cells.

1 reference

12 December 2020

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

12 December 2020

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

1 reference

12 December 2020

Angiogenesis and Cancer Control: From Concept to Therapeutic Trial

1 reference

12 December 2020

Phase I study of phenylacetate administered twice daily to patients with cancer

1 reference

12 December 2020

Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1019905127442

1 reference

Dimensions Publication ID

30 November 2017

0 references

1 reference